Kansas City Life Insurance Co. (KCLI)
(Delayed Data from OTC)
$37.50 USD
+0.51 (1.38%)
Updated Jul 23, 2024 03:41 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Kansas City Life Insurance Co falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 559 | 477 | 511 | 524 | 513 |
Cost Of Goods | 340 | 331 | 361 | 360 | 336 |
Gross Profit | 219 | 145 | 151 | 164 | 177 |
Selling & Adminstrative & Depr. & Amort Expenses | 150 | 166 | 138 | 148 | 147 |
Income After Depreciation & Amortization | 69 | -21 | 13 | 16 | 29 |
Non-Operating Income | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | 69 | -21 | 13 | 16 | 29 |
Income Taxes | 14 | -5 | 2 | 1 | 5 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 55 | -16 | 11 | 15 | 24 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 55 | -16 | 11 | 15 | 24 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 111 | 29 | 56 | 69 | 77 |
Depreciation & Amortization (Cash Flow) | 42 | 50 | 43 | 53 | 48 |
Income After Depreciation & Amortization | 69 | -21 | 13 | 16 | 29 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 9.68 | 9.68 | 9.68 | 9.68 | 9.69 |
Diluted EPS Before Non-Recurring Items | 5.67 | -1.67 | 1.11 | 1.57 | 2.52 |
Diluted Net EPS (GAAP) | 5.67 | -1.67 | 1.11 | 1.57 | 2.52 |
Fiscal Year end for Kansas City Life Insurance Co falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | 127.31 | 186.37 | 122.63 | 123.95 |
Cost Of Goods | NA | 86.80 | 83.52 | 80.10 | 82.38 |
Gross Profit | NA | 40.51 | 102.85 | 42.53 | 41.57 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 38.54 | 40.93 | 36.68 | 35.92 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 1.97 | 61.92 | 5.85 | 5.65 |
Non-Operating Income | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | 1.96 | 61.92 | 5.84 | 5.66 |
Income Taxes | NA | 0.41 | 12.83 | 1.24 | 1.19 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 1.55 | 49.10 | 4.60 | 4.46 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 1.55 | 49.10 | 4.60 | 4.46 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | 9.68 | 9.68 | 9.68 | 9.68 |
Diluted EPS Before Non-Recurring Items | NA | 0.16 | 5.07 | 0.47 | 0.46 |
Diluted Net EPS (GAAP) | NA | 0.16 | 5.07 | 0.47 | 0.46 |